Stenabolic raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-07-03. Anything still debated is marked as such rather than presented as settled.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human use | Investigational status in most countries |
| Sports status | Prohibited by WADA | Classified as non-approved or metabolic modulator |
| Common analytical method | LC-MS/MS | Used for trace detection in biological samples |
| Typical test matrices | Urine and blood | Sample choice depends on testing program |
| Human trial data | None published | Effects and safety are not established |
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
A U.S. State Department report on Zimbabwe states, "In response to social pressure, some families reportedly subjected their [LGBTQ] members to corrective rape and forced marriages to encourage heterosexual conduct. Such crimes were rarely reported to police. Women, in particular, were subjected to rape by male family members." Following the publication of an earlier report with similar wording, Zimbabwean journalist Angus Shaw said that lesbian women are raped by men to make them "enjoy" heterosexual acts and gay men are raped by women to "remove" their sexual orientation tendencies.
On the same day, National Assembly president Jorge Rodríguez issued a separate communiqué confirming the start of the joint agenda, framing it as part of a national unity effort following the earthquakes and emphasizing reconstruction and social stability without explicitly referring to electoral reforms. In September 2026, Interior minister Diosdado Cabello hinted 2028 as a possible year for election day, stating "I believe (the opposition) they'll go for 2028; whenever that is, the United Socialist Party of Venezuela will be there, ready to win."
== Emitters == Several different emitter configurations have been used for FD emitters, such as single tips, sharp blades and thin wires. Single metal tips can be made from etching wires either by periodically dipping them into molten salts or by electrolysis in aqueous solutions. Compared to other emitter types, the single tips have the advantage that they can reach the highest field strengths. In addition, well-defined geometric shape of a single tip allows accurate calculation of the potential distribution in the space between the tip and the counter electrode. For blades used as emitters, their ruggedness under the high electric field is one of their advantages. Different thin wires were also used as emitters, such as platinum wires and tungsten wires. Platinum wires are fragile, and tungsten wires are much more stable than platinum wires. Among those emitters, carbon-microneedles tungsten wires are the most widely used emitters in FD mass spectrometry.
Sources: en.wikipedia.org
== Other uses == VIP style, or VIP Car, a car modification trend Plymouth VIP, a luxury version of the Plymouth Fury (1966-1969) Vacuum insulated panel, a form of thermal insulation consisting of a nearly gas-tight enclosure surrounding a rigid core, from which the air has been evacuated Variable Information Printing, a form of on-demand printing VimpelCom, a stock symbol VIP Ecuador, an Ecuadorian airline VIP Industries, a luggage manufacturer based in India VIP's (restaurant), an American restaurant chain Virgil Partch, a cartoonist who signed his work Vip Virgin Islands Party, a political party in the British Virgin Islands Virology Science and Technology Institute of the Philippines, also known as the Virology Institute of the Philippines (VIP) Vision Inspired by the People, a political party in Belize Visually impaired person, a person with a decreased ability to see
=== Wes: The Meat-Stick Bully === First aired: 24 September 2009 Victim Chris has a problem with a tobacco spittin', hockey playing Texan and self-proclaimed "meat-stick", Wes. Mayhem enlists Tony Bonello to put this bully in his place. He was submitted 4 times and knocked out, but with an illegal head kick. Wes actually managed to knock down Tony Bonello which, apparently, upset the MMA fighter enough for him to break the rules. The kick to the head was hard enough that Wes could not remember where he was, or any of the fight. Because of the illegal kick, the bully received the $5,000 for that round. However, Wes refused it, stating "A knockout's a knockout," and then apologized to Chris by giving the money to him. Mayhem refers to Chris as his favorite victim because he is cute and adorable.
In the blockchain, bitcoins are linked to specific strings called addresses. Most often, an address encodes a hash of a single public key. Creating such an address involves generating a random private key and then computing the corresponding address. This process is almost instant, but the reverse (finding the private key for a given address) is nearly impossible. Publishing such a bitcoin address does not risk its private key, and it is extremely unlikely to accidentally generate a used key with funds. To use bitcoins, owners need their private key to digitally sign transactions, which are verified by the network using the public key, keeping the private key secret. An address may encode the hash of a bitcoin script that specifies more complex requirements to spend the funds. One common example is "multisig", in which multiple distinct private keys must mutually sign any transaction that attempts to spend the funds. Bitcoin transactions use a Forth-like scripting language, involving one or more inputs and outputs. When sending bitcoins, a user specifies the recipients' addresses and the amount for each output. This allows sending bitcoins to several recipients in a single transaction. To prevent double-spending, each input must refer to a previous unspent output in the blockchain. Using multiple inputs is similar to using multiple coins in a cash transaction. As in a cash transaction, the sum of inputs can exceed the intended sum of payments. In such a case, an additional output can return the change back to the payer.
Charles Edward Moody, Deputy Chief Executive, Engineering and Marine Training Authority. For services to Training. Derek William Charles Morgan. For public service in Wales. Patricia Morris. For political service. John Robin Mulholland, Agricultural Estates Manager, Crown Estate Commissioners. Herbert Neville Nahapiet, Chief Executive, UK Detention Services. For services to Engineering and to the Construction Industry. Robert Livingston Nelson, Director, Dounreay, UKAEA. For services to the Nuclear Industry. Malcolm Terence Newman, Range E, Her Majesty's Treasury Joan Mary North. For political and public service Jean Nugent, Nursing Director, St. Helier Hospital, Carshalton, Surrey. For services to Health Care. Geoffrey James Osborne, lately Grade 7, Department of the Environment. Alfred David Owen, Trustee, Community Development Foundation. For services to the community in the West Midlands. Anthony Frederick Parker, lately Courts Administrator, Lord Chancellor's Department. Pamela Margaret Parker, Vice President, All England Women's Hockey Association. For services to Hockey. Alan Edward Parkinson, Officer in Charge, Board of Inland Revenue. David Romer Paton. For services to the community in Aberdeen. Professor Christopher Charles Payne, Chief Executive, Horticulture Research International. For services to Horticultural Research. Ann Philippa Pearce (Mrs Christie), Author. For services to Children's Literature. Anne Pegington, Secretary, Royal College of Nursing's Welsh Board. For services to Nursing in Wales. Howard Wesley Petch, Principal, Bishop Burton College.
Sources: en.wikipedia.org
No. It is an investigational compound without approved therapeutic indications. It is sold for research purposes only in many jurisdictions.
Sports authorities prohibit it because it is not approved for human use and has potential performance-enhancing effects. It appears on anti-doping lists under non-approved or metabolic modulator categories.
Detection usually uses liquid chromatography-tandem mass spectrometry. The method targets the parent compound or its metabolites in urine or blood.
SR9009 is a synthetic research compound that binds and modulates the nuclear receptors REV-ERBα and REV-ERBβ. It is used in laboratory studies of circadian biology and metabolism, not as an approved medicine. It is also known by the informal name Stenabolic.